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These studies were designed to correlate the pharmacokine tics of 
perioperative prophylactic cefazolin with the degree of intraoperative blood 
loss in patients undergoing various types of surgery. Serial serum 
concentrations of cefazolin were also correlated with serum albumin 
levels, the duration and type of procedure, and the type of anesthetic. 
It was postulated that the results might help predict dosing regimens 
that will maintain therapeutic antibiotic levels perioperatively. 
Thirty-six patients were included in this study of antibiotic 
prophylaxis. Seven serial serum blood levels of cefazolin were drawn 
during the operative procedure throughout an eight hour period. The 
pharmacokinetics of the serum cefazolin levels of those patients with a 
small blood loss was compared to those with a large blood loss. The 
patients were divided into three arbitrary groups of small blood loss as 
defined as less than 1000cc and large blood loss defined as greater than 
3000cc and a third group of intermediate blood loss between these two 
The serum levels of cefazolin as determined by the area under the 
curve (AUC), were found to be significantly lower in those patients with a 
large blood loss, as compared to those patients with a small blood loss, 
283 vs. 134, <p<05). A large variation in the apparent volume of 
distribution was also noted in this study group. Only 17. of this variation 
in the volume of distribution could be attributed to differences in lean 
body mass. These results suggest a need for more frequent dosing of 
prophylactic antibiotics in those patients undergoing operative procedures 
in which there is substantial blood loss. 

An Hi31qricaL flullme jit _AittiiLifl_tiC- Proplmlaxla 
Antibiotic prophylaxis is strictly defined as the administration of an 
antimicrobial agent prior to bacterial contamination. Prophylaxis 13 to be 
distinguished from early therapy in that the latter is initiated immediately 
after the diagnosis of infection has been determined. An illustrative 
example would be the U3e of a prophylactic antibiotic prior to the 
inititiation of gastrointestinal surgery as the agent i3 administered prior 
to entering an internal viscus, In contrast, antibiotics administered prior 
to surgery to a patient presenting with pentrating abdominal trauma, 
would be considered early therapy as contamination has already occured 
in this case.1 Careful review of the literature reveals that many of the 
early studies of antibiotic prophylaxis fail to make a clear distinction 
between these two concepts. 
For centuries surgeons have long recognized the significance and 
sought ways to reduce the devastating effects of post-operative 
infections. The earliest examples of attempts to prevent post-operative 
infections date back to the 1500's when cauterization was routinely 
performed after amputation of the extremities.2 It is interesting to note 
that the field of bacteriology could have begun in the 1500's if the ideas 
of the Italian physician Girolamo Fracatoro had been accepted. Along with 
contributing to Copernicus' explanation of the solar system, in 1546 he 
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published an entire book on the spread of diseases by "tiny 
fa3t-multiplying bodies". Unfortunatly for Fracastorius, he was three 
hundred years ahead of his time.3 
it was not until the 1800’s when it became apparent that certain 
clinical factors could influence infection rates. One of the most notable 
experiments in antispetic clinical practice came in 1846 at the General 
Hospital in Vienna, Dr. Philipp Semmelweis noted a large discrepancy 
between the mortality rates from "childbed fever" (peurperal fever) in 
the maternity clinic between ward one (29,33%) and ward two (3%), The 
main difference between the two wards was that the medical students 
attended the patients on ward one directly after their anatomy class. 
Through a process of elimination the difference in mortality was found to 
be due to students carrying infections from their cadavers directly onto 
the patient wards. Subsequently, Semmelweis required everyone to wash 
their hand3 with clorinated water before birth3. This resulted in a 
reduction in the mortality rate to the same levels as ward two.4 
Tragically, this discovery was not heeded and did not find a place in 
surgery until decades later.5 
Despite observations such a3 thi3, many were reluctant to accept a 
bacterial origin of infection. Up until this time the causative agent of 
infections had remained elusive. One popular theory of infection invoked 
an ephimeral "miasma" which existed in the air.6 Another theory 
attributed wound infection to an adverse chemical reaction of oxygen in 
the air to the exposed tissues.7 
It was not until the 1870's that the germ theory began to gain wide 
acceptance. In 1840 Henle had revived the germ theory with his text; "On 
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Miasmas and Contagions".8 A student of Henle'3, Robert Koch, became one 
of the first professors of hygiene and bacteriology. Along with his 
influence in promoting a bacterial cause for infections, Koch was also 
noted for inventing new methods of culturing bacteria, the development of 
tuberculin, and bichloride of mercury 33 a bactericidal agent. His studies 
led to the formulation of "Koch's law", which serves as the basis for all 
modern bacteriology.9 
Another great figure in the field of bacteriology was Louis Pasteur. 
Pasteur studied a variety of i3sue3 closely related to the medical field. 
One of his interests was in the field of microorganisms which cause 
disease in humans, Pasteur proved that fermentation was caused by 
fungi or bacteria.10 He is credited with having discovered staphylococci 
and streptococci along with explaining the toxic effects of bacteria. He 
was a strong proponent of bacteria as the causative agents in various 
infections.11 The work of Pasteur and Koch issued in the "Golden age of 
bacteriology".12 Their work set the foundation for future research. 
The concepts of bacteriology had immediate applications in the field 
of surgery. It was at this time that some surgeons began to attempt 
methods to reduce the incidence of bacterial infection. Joseph Lister 
became one of surgery's outstanding pioneers in the field of antisepsis. 
Lister was the first to use a surgical antiseptic solution. The year 1667 
saw the advent of Lister's carbolic spray as a means of antisepsis.13 It 
is interesting to note that despite the vast evidence in favor of the 
concept of bacteriology, even at this time the field of bacteriology had its 
skeptics. Florence Nightingale, who 13 well noted for her two books whose 
main points emphasized soap, cleanliness, fresh air, and one patient to a 
bed, knew nothing about bacteria and doubted Lister's theory that 
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bacteria even existed.14 
Lister's paper on antisepsis was published in the Lancet and his 
ideas gained wide acceptance making him world renownd.15,16 Refinements 
were made on Lister's original techniques and other antiseptic agent3 
were di3coverd such as iodine and bichloride of mercury.17 The principles 
of antisepsis were later carrried to their logical conclusion of total 
surgical a3ep3i3. Ern3t von Bergman proposed the sterilization of surgical 
instruments.18 Dr. Bernhard Kronig was instrumental in promonting the 
use of surgical gloves.19 Johannes von Mikulicz-Radecki wa3 one of the 
first to U3e a face-mask during surgery. Perhaps the ultimate extension 
of antisepsis is in the mouthwash which honors Lister's name, Listerine.20 
The proper use of Lister’s carbolic spray during surgery. 
(From Glaser, The Road to Modern Surgery, 1960 
Lutterworth Press, London.) 
The history of early antisepsis i3 significant as it describes the 
progression of a new understanding of infectious complications of surgery 
and fostered the development of measures to counter infection. These 
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discoveries transformed the field of surgery allowing new operations of 
even greater magnitude in a variety of anatomical locations previously 
considered prohibitive.21 
Early Antibiotic Prophylaxis 
It was not until 1939 that the first reported use of an antimicrobial 
for surgical prophylaxis appeared. Some of the initial studies of 
antibiotic prophylaxis are incongruous due to variations in the timing of 
antibiotic administration. Indeed, in many of these early studies the 
authors failed to make a clear distinction between early therapy and true 
prophylaxis. in a study by Jensen using topical sulfanilamide in open 
fractures it was found that the post-operati ve infection rate was 
reduced from 27% to less than 5%,22 This study issued in the concept of 
prophylactic antibiotics in surgery along with several decades of 
controversy a3 to the details of prophylactic antibiotic usage along with 
guestions as to the validity of the concept as a whole. 
In 1945 as the First World War was drawing to a close Meleney 
published a report on the use of prophylactic topical and systemical 
sulfonamides in surgery.23 It was hoped that this study would suggest a 
possible role for preventing infection in the enormous number of injured 
soldiers. Using abundant information gathered from civilian casualties 
Meleney was forced to the conclusion that overall the controls did better 
than those treated with the sulfonamides. Despite certain studies such as 
this indicating the ineffectiveness of these agents for prophylaxis, the 
search for the beneficial effects of prophylactic antibiotics continued. 
With the advent of penicillin in the United States in 1942 a new 
! 
6 
agent entered the arena of antibiotic prophylaxis. it initially found its 
main use in the field of surgical obstetrics.24 By the late 1940^3 
streptomycin and tetracycline became widely available and along with 
penicillin began to be prophylactically administered to parturient women.25 
These agents showed a clear benefit in reducing post-operative morbidity, 
especially in patients at high risk for infection. 
Yet further support for the use of sulfonamides and penicillins came 
in the field of gastrointestinal surgery. In 1947 Griffin reported the 
benefit of these agents in reducing the rate of infection for appendectomy. 
During the period from 1935 to 1947 the mortality associated with an 
appendectomy was reduced from 7,5% to 0.9%, While these were many 
factors involved, this reduction was attributed in large part to the 
effects of prophylactic antibiotics,26 
While the beneficial effect of prophylactic antibiotics in certain 
situations was apparent it was al3o becoming evident that the 
indiscriminate U3e of these agents could have detrimental effects, A 
study by Prince in 1946 examining the effects of prophylactic antibiotics 
for transurethral resection of the prostate showed a beneficial effect of 
the antibiotic in some cases yet also revealed the emergence of resistant 
strains of microorganisms such as Pseudomonas 3p.27 This was one of 
the earliest papers to discuss the difficulty of balancing the therapeutic 
effects of reducing the bacterial counts of certain strains while 
simultaneously avoiding the proliferation of competing strains. 
By 1954 the use of prophylactic antibiotics for many procedures had 
gained wide acceptance, although many aspects of their effective 
administration had yet to be resolved, A study by McKittrich and 
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Wheelock examined the potential benefits of antibiotic prophylaxis against 
the hazards associated with the indiscriminate use of these agents.28 
They pointed out the risks of the selection of resistant strains, the 
expense involved in the routine use of antibiotics, and the potential 
toxicity of these agents. in their study examining the use of antibiotics 
in abdominal surgery they concluded that there was not 3ufficient benefit 
to justify the U3e of these agents when weighed against the negative 
aspects of antibiotic prophylaxis. in retrospect it is to be noted that 
their conclusions were flawed as they were not established on the 
premise that prophylaxis should be started prior to the initiation of 
surgery. Had they controlled for this factor their results would 
undoubtably have differed. 
The evolution of the use of antibiotics during the treatment of burn 
cases revealed the importance of the method of administration along with 
the type of agent used. The use of systemic antibiotics for burn cases 
was reported as early as 1946. There were conflicting reports as to the 
efficacy of systemic antibiotics in burn cases at that time.29-’30 Part of 
this controversy centered around the fact that the systemic antibiotics 
are effective against early superficial wounds yet are less efficacious 
against major burns and sepsis in which they often select for resistant 
strains.31 In 1960 it was noted that topical penicillin cream greatly 
reduced the rate of infection in burn cases.32 In 1965 Moncrief and Moyer 
proposed the barrier technique to reduce the degree of bacterial 
colonization by applying prophylactic antibiotic coverage to the surface of 
the burnt tissue.33 With further refinement of this technique by Lindberg 
and Polk, decreased post-operative morbidity and mortality were 
34 obser v ed. 
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The 1960's was a period of further refinement in the use of 
antibiotic prophylaxis. Antibiotics were being used frequently, often with 
little regard to the actual risk of infection. In many cases "prophylactic" 
antibiotics were administered after surgery rather than before. There 
were those who criticized this indiscriminate use of these agents, 
although there was no official consensus as to the optimal point for 
initiating antibiotic administration. 
Mile a and_lhfi_ "D_g£iajiy.g -PaLiad.." 
A study by Mile3 assisted in clarifying this issue by showing that 
there was an optimal period during which antibiotics had their maximal 
prophylactic effect.35 His study revealed that the antbiotics had to be 
present within a window period of three hours of the time of the 
initiation of the lesion. By three hours after the bacterial inoculation the 
antibiotics had lost the majority of the observed prophylactic action. 
Mile3 termed this phenomenon the "decisive period" for infection and 
defined it as that period of time after the primary lodgement of bacteria 
that manipulation of host defense factors could impact on the ultimate 
course of the infection. 
An elegant study by Andriole and Lytton examining the effect of 
increased pressure on intradermal staphylococcal infections also 
demonstrated a critical period of increased tissue susceptibility to 
infection. This study demonstrated a window period, much like that 
descrebed by Miles, of approximately four hours beyond which increased 
tissue pressure failed to alter the degree of erythema and induration 
observed in the animal model. Studies such as these provided a 




Mean 24-hr. lesion diameter 
(mm) 
Lesion Age at Penicillin Injection 
(Hours) 
Effective period of preventive antibiotic action in 
experimental surgical lesions. 
(From Conte, Antibiotic prophylaxis in surgery, 1984, 
Lippincott, Philadelphia.) 
In the seventies and eighties many studies in particular types of 
surgery with specific agents chosen to counter the anticipated 
microorganisms encountered were undertaken. Although these studies 
were often of variable quality, they secured a role for antibiotic 
prophylaxis in specific types of surgery.37 With the advent of wound 
classification surgeons had an official guideline for identifying those 
wounds that would most likely benefit from prophylactic antibiotics.38 
The advantages of prophylactic antiseptic wound irrigation were also 
explored and further refined.39 Further studies during this period helped 
to define an optimum duration for the administration of antibiotics. While 
many surgeons were continuing prophylaxis for several day3 
post-operatively, studies during this period revealed this was unnecessary 
and that prophylactic antibiotic coverage could be restricted to a 
shortened perioperative period.40'41 During this period optimum methods 
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of administration for various procedures were also defined.4d in 
conjuntion with the work of Miles and Andriole, it was discovered that 
perioperative short-term prophylaxis was most effective in procedures 
with significant bacterial contamination of the operative site and with 
subsequent high infection rates and in procedures frequently followed by 
serious infection.43 
The use of prophylactic antibiotics has developed over the past sixty 
years via a number of reports concerning various aspects of this topic 
which have gradually coalesced into the present regimes. From the large 
number of studies published, the basic elements determining effective 
antibiotic prophylaxis have emerged. It is now known that an effective 
prophylactic regimen should be directed against the most likely infecting 
organisms but need not eradicate every potential pathogen; rather the 
goal is to decrease their numbers below the critical level necessary to 
cause infection. Today, the type of antibiotic used, its duration of use, its 
spectrum of coverage, and designated time of administration are designed 
to suit the particular operation and the specific microorganisms which the 
surgeon anticipates encountering.44 Through a continual process of 
investigating various aspects of antibiotic prophylaxis in different 
operations surgeons were able to gradually refine the process of 
prophylaxis to obtain optimal therapeutic results. This process of 
ultimate refinement 13 one which continues to this day. 
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The mam rational for the administration of prophylactic antibiotics 
is in the potential of these agents to reduce surgery-related wound 
infections. Certain factors have been clearly identified as risks for 
po3t-operative wound infections. Modifying factors which might influence 
surgeons to use antibiotics with either greater frequency or in instances 
in which they might not otherwise U3e them include; the implantation of 
prosthetic devices, remote infection, immunosuppressive agent3, 3teroid3, 
diabetes, radiation. obesity. and extremes of 45 age. ^ Despite the 
recognition of these many factors which exert an influence on the 
effectiveness of antibiotic prophylaxis, to date there have been no 
definitive studies directly related to the effect of blood loss during the 
operative procedure on the serum levels of prophylactic antibiotics. A 
survey of the literature in fact reveals few articles relating simply to 
the effects of surgery itself on the levels of antibiotics, or other drugs 
for that matter. Thi3 is clearly an area which could benefit from further 
investigation. 
Altered antibiotic dosing reouir.emfin£3-ja.surreal... 
A wide variety of pathophysiologic changes can occur in the surgical 
patient. It i3 reasonable to assume that these alterations in normal 
physiology may contribute to altered kinetics of therapeutic agents 
administered.46 It has been shown that there can be wide interpatient 
variations in antibiotic dosage requirements in surgery patients with 
normal renal function despite standard dosing. A study in 1980 by Za3ke 
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looked at 242 surgery patients who were treated with gentamicin for 
gram-negative pneumonia, peritonitis, urinary tract or 30ft tissue 
infections with clinical signs of 3epsis. While the study did not directly 
address the issue of serum gentamicin levels during surgery it did 
emphasize the important fact that surgery patients with otherwise normal 
renal function can have wide variations in antibiotic half-lives, 
distribution volumes, and corresponding gentamicin dosage and interval of 
administration requirements. The 3tudy concluded that 47% of the 
patients actually required higher dose3 than those normally reccomended 
for non-surgical patients. The 3tudy al30 concluded the standard 
gentamicin dosing interval of eight hours resulted in either 3ubtherapeutic 
or potentially toxic serum concentrations in three of every five patients, 
the majority of patients requiring more frequent dosing.47 
The importance of this finding cannot be underestimated as other 
studies have shown that subtherapeutic antibiotic levels in surgical 
patients can have a significant impact on patient morbidity.48'49 
Recognizing that there were several factors commonly known to 
contribute to interpatient variability 3uch as altered renal funciton, body 
temperature, and lean body mas3, thi3 study concluded that the 
distribution volume for gentamicin is not consistent in surgical patients 
who commonly have pathophysiological changes, such as peritonitis or 
congestive heart failure. 
Uariations in distribution volume in 242 surgery patients. 
(From Zaske, D., Cipolle, J. Surgery, 1980, 87 2) 
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Reed has al30 elegantly demonstrated that this variation in the 
volume of distribution cannot be explained simply by differences in body 
weight among patients. In hi3 study examining pharmacokinetic monitoring 
of antibiotics in 3urg ical intensive care patients. he shows that predicted 
serum levels of antibiotics are often far below the actual 
pharmacokinetically determined v alues. Much of this variation is 
attributed to large alterations in the v olume of distribution. It is 
futhermore noted that only 10% of differences in the apparent volume of 
distribution are related to alterations in body weight among the 
patients.50 
60 : 
Relationship between apparen 
body uieight for (A) aminoglyc 
(From Reed, L., Wu, A. J. of Ti 
120 - 
0 20 JO 60 80 IU0 
Weight I kg) 
volumes of distribution 
isides and <B> vancomycin, 
auma, 1989, 29:11) 
120 
and 
Increased Need for Antibiotics in Burii-Eafciarita 
Burn patients represent a special 3ub~category of surgical patients 
who have a variety of pathophysiologic derangements. In order to better 
understand the various factors affecting the 3erum antibiotic levels of 
patients during surgery, and the special case of burn patients, it i3 
necessary to investigate the systemic effects which are mo3t frequently 
observed in association with such trauma. There are numerous 
pathophysiologic changes accompanying burn trauma which can alter the 
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distribution of administered drugs, including cardiovascular changes, 
alterations in renal and hepatic function, and fluctuations in plasma 
protein concetrations.51,52 Other complicating factors such as sepsis, 
drugs that induce or inhibit drug metabolism, hepatotoxic or nephrotoxic 
drugs, malnutrition, parenteral nutrition, preexisting systemic disease, and 
endogenous burn-induced substances can all contribute to alterations in 
drug distribution and response.53 
There are two metabolic phases to the patient sustaining a burn 
injury. The acute phase, immediately after injury, is marked by 
decreased blood flow to the tissues.54 This decreased blood flow i3 
brought about by multiple factors such as; hypovolemia, depressed 
myocardial function, increased blood viscosity, and the release of 
vasoactive substances.55 These factors will all contribute to altered 
pharmacokinetics of any drugs administered. 
in the event of adequate resuscitation, a second phase of burn 
injury, begining 48 hours after the original insult ha3 been identified a3 
the hypermetabolic or recovery phase which is associated with increased 
blood flow to the organs and tissues.56 During this time total body and 
hepatic oxygen consumption a3 well as glucose and protein turnover by 
the liver are increased.57 These alterations should also affect the 
kinetics of therapeutic agents administered at thi3 time. 
The plasma concentrations of drugs which are highly protein bound 
may be deranged in burn patients as plasma protein concentrations have 
been observed to be altered in both the acute and recovery phases of 
burn injury.58 It has further been noted that while the concentration of 
albumin i3 decreased, the concentration of the acute phase reactant. 
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alpha-acid glycoprotein is increased,59 Thi3 relative change in the 
percent protein composition can result in contradictory effects on 
different therapeutic agents. While the half-live3 of some agents such as 
the tricyclic antidepressants is increased, the binding of other agents 3uch 
as certain antibiotics is decreased,60 
Previous studies have demonstrated a need for higher than normal 
doses of certain antibiotics in burn patients in order to maintain 
therapeutic levels.61 The two main factors dictating these increased 
requirements are the enhanced elimination of the drugs by the kidney 
resulting from burn-induced increases in the glomerular filtration rate62 
and the direct drug loss through the burn wound.63 The loss of agents 
through the burn wound may be more significant in the infant than the 
adult because of the infants relatively high surface-area to body-weight 
ratio. in summary, there are multiple factors to be taken into 
consideration in obtaining optimum antibiotic dosage requirements in the 
burn patient. The situation 13 further confounded by the co-administration 
of drugs that can induce or inhibit the metabolism and excretion of other 
drugs. The pharmacology of thi3 population i3 also complicated by 
changes in target-organ sensitivity induced by multiple endogenous 
substances released in response to, or as a consequence of, the. burn 
injury, as well as from malnutrition, physical immobilization, and various 
iatrogenic factors.64 
It has been shown that burn patients with normal renal function can 
have an increased need for antibiotic coverage irrespective of surgical 
blood loss. A 1978 study by Zaske. examined the serum levels of amikacin 
in burn patients,65 In contrast to other surgical patients, this study 
found that burn patients demonstrate a more rapid rate of elimination of 
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amikacin than expected. The half-life of the drug was decreased such 
that the standard recommended do3e3 frequently resulted in 
subtherapeutic levels of amikacin. The study concluded that many burn 
patients require a more frequent dosing interval and consequently a 
higher daily dosage of amikacin. The author suggested the wide volume 
changes occuring in burn patients wa3 one of the main factors 
contributing to these altered pharmacokinetics. Thi3 3tudy emphasized 
that systemic antibiotic administration in the burn patient i3 complex and 
deserves special consideration, including close monitoring of plasma drug 
concentrations. 
The Effect of the Duration of Surgery 
It has been shown that the duration of an operative procedure can 
have a significant impact on the occurence of wound infection. In a 3tudy 
by Kaiser comparing the prophylactic use of cefoxitin to a triple 
combination of erythromycin, neomycin, and cefazolin in colorectal 
operations, it was found that among those patients undergoing a surgical 
procedure of le33 than four hours only 8.7% incurred a wound infection. 
In those patients whose procedures lasted greater than four hours the 











The effect of the duration of surgery on the incidence of 
uuound infection. 
(From Kaiser, A. Ann. Surg 1983, 198=4) 
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There are several factors which may contribute to these 
observations. It seem3 reasonable that an operation which lasts greater 
than four hours 13 one which i3 technically more difficult and more prone 
to infectious complications. it may also be that some procedures last 
greater than four hours due to complications which arise during the 
operation and which may also predispose to infection. Certainly, any 
prolonged period for bowel surgery provides a greater opportunity for 
infection from gastrointestinal microorganisms. it is also likely that a 
technically more difficult procedure or one in which there are 
complications will be associated with a greater intraoperative blood loss. 
Regardless of the cause of this increased incidence of wound infection, it 
illustrates the importance of adequate antibiotic coverage for prolonged 
operative procedures. 
The Effect of Hemorrhagic Shock on Antibiotic Levels 
Previous studies by Livingston and Miles have shown that 
dehydrationa! 3hock reduces the effectiveness of penicillin to control an 
intradermal Staphylococcus aureus infection.67 it has been shown that 
hemorrhagic shock increases the susceptibility to wound infection with S. 
aureus that is not reduced despite resuscitation and standard prophylactic 
antibiotic U3e.68 Furthermore it has been shown that this decreased 
ability to combat infection persists for up to 5 days after the 
hemorrhagic m3ult. These experimental observations 3erve as evidence 
that current conventional administration of prophylactic antibiotics may 
be ineffective in the presence of shock.69 
Previous reports, especially in the field of penetrating abdominal 
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trauma, have already shown a positive correlation between perioperative 
shock or excessive blood loss and a higher risk of infection, even in the 
presence of appropriately administered antibiotics.70,71 These studies 
have 3hown that hypotension is a significant ri3k factor for the 
development of late infectious complications in these injured patients. 
Still other reports of non-trauma patients have demonstrated that 
intraoperati ve hypotension increased the incidence of infectious 
complications that occur after operations on the colon and other areas of 
the gastrointestinal tract.72 
A study by Livingston looked at quantitative correlations between 
the degree of shock and it3 influence on infection rates.73 Thi3 study 
examined the effect of hemorrhagic 3hock on Sprague-Dawley rats with 
the do3e and duration of antibiotic coverage necessary to reduce 
morbidity and mortality. These studies in an experimental amrnal model 
have shown that increasing both the dose and duration of antibiotic 
administration is more effective than standard short-course antibiotic 
prophylaxis in preventing experimental infection after hemorrhagic shock. 
In this study Sprague-Dawley rats were injected with one of three 
concentrations of Staphylococcus aureus 3ubcutaneou3ly. Five treatment 
groups were then analyzed. The treatment groups consisted of one 
control and four consecutively larger doses of cefazolin. Results were 
derived by measuring abscess number, weight, and diameter seven days 
after inoculation. 
The results of this study 3how that hemorrhagic shock significantly 
increased the susceptibility to infection compared with the un3hocked 
controls; however, the magnitude of change was related to the number of 
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bacteria injected. At the lowest inoculum, 3hock resulted in a 3ma11 
increase in abscess number, with a minimal increase in size. With an 
inoculum of 10x8 bacteria, abscess diameter increased significantly 
compared with un3hocked animals. After shock, inoculation with 10x10 S. 
aureus resulted in a mortality rate of 100% of the controls, compared 
with that of unshocked ammal3 of 20%. 
Table 2. Effect of 10s S. Aureus. Hemorrhagic Shock, and CEF on Abscess Number. Diameter, and Weight 
No Shock Shock 
Abscess Control Short Long Mega Mega-Long Abscess Control Short Long Mega Mega-Long 
(n - 20) 20 9* ND 3t 37 (n - 20) 20 20 16 II 41 
Diameter (mm) 11.0 2 1.9 6.2 2 1.3* ND 2.8 2 0.67 2.3 2 0.6t Diameter (mm) 14.2 2 2.2 9 9 2 1.4* 5.6 2 2.77 5.6 2 1.67 4.2 2 1.97 
Wtijhl (mg) 401 2 147 129 2 40* ND 17 2 7t 24 2 8+ Weight (mg) 511 ±135 194 2 71* 92 2 82- 73 2 46- 32 2 307 
• p < 0.05 vs. control. } p < 0.05 vi. all other groups. 
t p < 0.05 vj. control and short. ND - not done. 
The effect of hemorrhagic shock on abscess number. 
diameter, and ujeight. 
(From Livingston, D. Ann. Surg., 1988, 208 4) 
This 3tudy illustrates that as ho3t defenses are depressed, fewer 
bacteria are necessary to create an infection. Miles has shown that the 
pattern of bacterial elimination i3 such that 95% of the bacterial 
challenge was eliminated by local ho3t defenses during the first 4 hours 
of the decisive period.74 Factors such as local vasoconstriction induced 
by epinephrine and hypovolemic shock led to actual bacterial growth 
instead of elimination during the decisive period, resulting in larger lesion 
size. 
Since shock results in multiple immunologic derangements, it i3 
probable that hemorrhagic 3hock alters local ho3t defenses by interfering 
with initial bacterial elimination during the decisive period and affects 
systemic host defenses by decreasing the ability to kill the bacteria 
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remaining after the decisive period,*75 In accord with previous work by 
these authors, it ha3 been demonstrated that, after shock, a standard 
prophylactic antibiotic regimen was ineffective in reducing infection, 
despite resuscitation and the presence of drug levels in the tissue greatly 
exceeding those recommended for killing bacteria/6 
The literature reveals a variety of articles relating shock to 
infection rates. In evaluating patients in 3hock relative to normotensive 
patients in ca3es involving penetrating abdominal trauma, a study by 
Jone3 showed that despite receiving standard antibiotic prophylaxis, the 
infection rate in shock patients was 30% while that in the normotensive 
patients was 14% .77 A study by Nichols showed similar results with 
infection rates in shock patients of 37% compared to 14% in normotensive 
patients.78 Other studies have confirmed these findings and shown that 
the infection rate relates to the severity of the injury, blood loss, and 
possible decreased host resistance.79 
These studies show that after 3hock, a standard prophylactic 
antibiotic regimen was ineffecive in reducing infection, despite 
resuscitation and the presence of drug levels in the tissue greatly 
exceeding those recommended for killing bacteria. The improved efficacy 
of higher doses may be due to a greater and sustained reduction in the 
bacterial inoculum during the decisive period, as opposed to standard 
dose3 and timing of antibiotics in which a nadir of ineffective or no 
antibiotic levels exist,80 
Although recent randomized, prospective clinical trials comparing 
antibiotic regimens after abdominal trauma have not shown benefit from 




hemorrhagic shock,1 a careful analysis of these studies demonstrates a 
35% infection rate in patients who sustained hemorrhagic 3hock after 
trauma, compared with a 10% infection rate in normotensive patients. 
This discrepancy is comparable to the infection rate that results after 
{ abdominal trauma when no antibiotics are U3ed and demonstrates that 
standard antibiotic dose and schedule are ineffective in patients who have 
sustained shock and bacterial contamination.82 
In summary, standard antibiotic prophylaxis is sufficient to combat 
infection when host defenses are normal or when host defenses are 
abnormal and bacterial contamination is small. Depression of ho3t 
defenses produced by shock accentuates the importance of antimicrobials 
in combating infection. in this setting, increasing the peak tissue 
antibioitic/MiC ratio by increasing antibiotic dose and duration of therapy 
decreases the incidence and magnitude of infection, and a longer course of 
antibiotics may be necessary for apppropriate prophylaxis against 
infection in this setting. Modification of antibiotic adminstration bu 
increasing the dose 3 and duration of drug decreases experimental S. 
aureu3 infection after hemorrhagic shock and deserves further 
examination in the clinical setting. 
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Cefazolin in Antibiotic Prophylaxis 
Cefazolin was chosen for this study as it is one of the most 
commonly used agents for surgical antibiotic prophylaxis. An effective 
prophylactic regimen should be directed against the most likely infecting 
organisms, but need not eradicate every potential pathogen; rather the 
goal is to decrease their numbers below the critical level necessary to 
cause infection. 
The use of therapeutic antibacterials can often be accomplished with 
great precision, since the offending organism is usually known, it3 
behavior understood, and its sensitivity to the variety of agents available 
easily determined. In contrast, there are few situations in which 
prophylactic antibacterials can be chosen with equal precision and their 
overall value measured. Thus, the choice of a prophylactic antibiotic is 
based on previous experience with the type of organisms commonly 
encountered and the kinetic aspects of the drug chosen. 
Cefazolin has excellent gram-positive coverage along with good 
anaerobic coverage. It has an extended serum half-life compared to the 
other first generation cephalosporins due to its extensive plasma-protein 
binding. It also has a lower cost than other second and third generation 
cephalosporins. For most procedures cefazolin has an advantage over the 
other first generation cephalosporins because of its longer half-life and 
the fact that it causes less pain with intramuscular injection. Indeed, 
cefazolin 13 the reccomended agent for a variety of surgical procedures 
including; prosthetic valve and other open-heart surgery, arterial surgery 
involving the abdominal aorta, orthopedic surgery such as total hip 
replacement, internal fixation of fractures, head and neck surgery, biliary 
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tract surgery, vaginal or abdominal hysterectomy, high ri3k cesarean 
section, second-trimester abortion, and all varitie3 of traumatic wounds. 
Studies have shown the ability of cefazolin to maintain sufficient 
tissue levels in surgical incisions. A study by Polk showed that cefazolin 
achieved and maintained, for a period reasonable for the completion of 
major abdominal operations, minimum inhibitory concentrations for all 
bacteria ordinarily thought to be within their spectrum. When compared 
to another first-general ion cephalosporin, cefalothin, it was found that 
this drug attained, but did not maintain, wound levels consistent with 
effective antimicrobial activity, even in 2 gram doses.83 
The frequency with which cefazolin is used and its favorable kinetic 




Materials and Methods 
Patient groups: There were three groups of patients based on the degree 
of observed blood loss. The various surgical procedures observed in the 
study included: hand surgery, prosthetic implants (i.e,, hip replacements, 
fracture patients, spine fusions, implant breast reconstructions, etc,), and 
burn surgery or trauma surgery. The types of surgery differed with 
regards to the anticipated degree of blood 1033, While procedures such as 
hand surgery are associated with a minimal degree of blood los3, other 
procedures such as burn and trauma surgery tend to be associated with 
more significant degrees of hemorrhage. 
Thi3 project received complete approval from the Yale University 
Human Investigation Committee, Although the study was approved for 
verbal consent alone, in all cases written or verbal consent was obtained 
and the details of the study were explained along with any potential risks. 
It was emphasized that patients were free not to participate and to 
withdraw from the 3tudu at any time should they so desire. Patients 
also received a personal copy of the consent form. 
Eatient evaluation par.aoielg-.ca: Each patient was analyzed according to 
the following variables: age, sex, height, weight, type of anesthesia, liver 
function, and vital signs, In addition, renal function was evaluated with 
serum creatinine and blood urea nitrogen values which were obtained 
prior to surgery and post-operatively. The degree of urine output wa3 
further evaluated as evidence for adequate renal function. Serum protein 
and albumin levels were determined as cefazolin i3 known to be 
approximately 85% protein bound. Hematocrit and serum hemoglobin were 
also determined for each patient. 
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Prophylaxis: Cefazolin, the most commonly used perioperative prophylactic 
antibiotic, was used for these studies: cefazolin, at a dosage of 1 gram IV 
every eight hours, wa3 first administered to the patient at induction of 
anesthesia in the operating room. This dose was diluted in approximately 
8cc of normal saline and injected as a bolus just prior to the initiation of 
surgery. Serum levels were determined by drawing 6 ml blood samples in 
each patient at 5, 15, 45, 90, and 120 minutes after cefazolin 
administration, and then at four, and eight hours after administration. 
Any deviations in sampling from thi3 schedule were noted at the time of 
surgery. Samples were drawn from either a heparin-lock intravenous 
catheter or, when available, from an arterial catheter. The samples 
were collected in standard red top tubes and refrigerated within two 
hours of drawing. The samples were then centrifuged and frozen within 
six hours of refrigeration. 
Serum cefazolin levels were determined by standard bioassay. This 
technique in our observation is accurate within 95% confidence limits (5% 
standard error). Concentrations were measured by microbiological assay 
with the agar well diffusion method. All samples were run in duplicate to 
ensure consistency. 
Estimating blood loss: Blood loss was recorded using estimates provided 
by the respective surgeon and anesthesiologist also taking into account 
other indicators of blood and fluid loss such as the volume of crystalloid 
administered, amount of packed red blood cells administered, and the 
volume of blood in the vacuum containers. This empiric system wa3 
deemed superior to other methods such as dye dilution techniques and red 
blood cell labelinq which are cumbersome, and regardless are never used 
in common clinical practice, and would thus be inappropriate to the 
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standard clinical situation. Red blood cell labeling involves injecting 
patients with radioactive Cr51 and the calculated values using this method 
are affected by 3uch factors as whether the blood sample 13 removed 
from the arteries or veins. Dye dilution techniques measure plasma 
volume rather than total blood volume and are subject to various 
complicated correction factors such as the presence of edema and 
variations in renal excretion of the due. For patients with small blood 
1o3s of less than lOGOcc, the 3urgeon'3 and anesthesiologist's estimates 
were averaged. For cases of large blood loss of greater than 3Q00cc, 
the number of units transfused was heavily weighed as a factor in 
determining the magnitude of total blood los3. 
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Aaaau. Ee oc educ sa. 
A standard bioassay procedure was employed to determine the serum 
levels of cefazolin present in each sample,84 All concentrations were 
measured by microbiological assay with the agar well diffusion method. 
This technique is accurate within 95% confidence limits (5% standard 
error).85 All blood samples were refrigerated within two hours of 
drawing in order to preserve the maximum bioactivity of the antibiotic. 
When all seven of the samples for an individual patient had been collected 
after eight hours they were spun to obtain the serum. The serum was 
carefully stored in labelled containers and immediately frozen. Specimens 
i were frozen at -15 degrees celcius until they were assayed (<2 weeks). 
! This period of storage did not affect the assay results. Reconstituted 
cefazolin has been shown to be stable for 24 hours at room temperature, 
96 hours at 5 degrees cel3iu3, and three months at -15 degrees Celsius.86 
Studies have shown no significant change in the bioactivity in the 
cefazolin upon thawing provided it 13 within the time limits specified 
I above.87 
1 
A running log was maintained on all samples which were coded 
according to the patient's name and unit number. Each sample was then 
given a unique sample code. This information was recorded both in the 
log and on a label placed on each storage vial. 
The bioassay was performed by first preparing the standards from 
samples of reference cefazolin which were kept in sealed containers in a 
dessicator which was maintained at 4 degrees celcius a3 the powder is 




standards were prepared as 1 mg/m] in a .1 M phosphate buffer at a pH 
of 8.0, 
I 
Working cultures for the bioa3say were prepared by adding two 
drop3 of a Staphylococcus aureus (Boston 3tram) suspension to 25 ml of 
trypticase soy broth (TSB) in a 100 ml bottle. Thi3 was then incubated 
overnight at 37 degrees celcius, Thi3 culture was held at 4 degrees 
i 
celcius between uses and was not used for a period exceeding two weeks. 
The agar plates were then prepared by dissolving Trypticase soy agar on 
a hot plate with stirring. The solution was then sterilized in the 
autoclave for 20 minutes at 15 pounds pressure and 121 degrees celcius. 
This wa3 then stored in the refrigerator until needed. The autoclaved 
agar medium was then melted and allowed to cool to 45 degrees celcius. 
The working culture of Staph was then vortexed and diluted 1:4 in the 
Trypticase Soy Broth. Then .1 ml of the diluted Staph was added to 35cc 
of the agar medium. This was swirled and poured into a bsoassay plate. 
The plates were left at room temperature until hard. The plates were 
then refrigerated until needed. 
When the assay was to be performed the assay plates were allowed 
to warm to room temperature. Wells for antibiotic standards and for the 
patient's serum were punched out in duplicate using a standard 4 mm 
punch. Each well was filled with 20 microhters of appropriate samples 
and standards. The plates were incubated overnight at 37 degrees 
celcius. The zones of inhibition were then measured and the concentration 
of the drug in the patient's serum was calculated from linear regression 




Thirty-three patients were divided into three groups based on the 
degree of blood loss. The three groups were defined as those patients 
with les3 than iOOOcc blood loss, those between lOOOcc and 3000cc and 
finally, those patients with a blood loss in excess of 30QGcc, These 
groups were designated as low, intermediate, and high blood I033 
categories. There were twenty-two, four, and 3even patients in each 
respective group (figure 1). 
1 The data from all patients was analyzed according to both a one 
compartment and a two compartment model of antibiotic distribution. The 
two compartment model is known to be the most accurate representation 
I 
! of the pharmacokinetic distribution of cefazolin. In a few cases the one 
compartment model was required to accurately describe the data. 
Approximately 25% of the patients required a one compartment model to 
evaluate their pharmacokinetic parameters. In these cases there was an 
insufficient number of data points in the alpha distribution phase causing 
| the A and alpha terms to poorly fit a two compartment model. The 
fitting characterized the distribution and elimination of the drug to give 
the area under the curve, which represents an integrated marker of body 
exposure to drug. 
By exposing the data to a rigid statistical analysis it was 
discovered that three of the patients had highly deviant serum values of 
cefazolin. In each case it was found that the observed serum decay 
profile could not be accurately described by either the one or two 
compartment model in the case of patient *42 the serum values were 
essentially linear over time and failed to show a significant serum decay 
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profile. In patients *25 and *41 the data points were internally 
inconsistent. The data points appeared dichotomous such that the alpha 
distribution phase could not be correlated with the beta distribution phase. 
Due to the complicated logistics involved in obtaining the samples and 
performing the bioassay, several possible explanations for these 
variations are apparent. It could be that some of the samples were not 
pure blood as some were drawn from arterial lines which could have been 
inadvertantly flushed prior to drawing the sample. A significant 
complication involved some surgeons who would redose the antibiotic prior 
to the standard eight hour interval. Usually this complication was 
detected, however, it offers an explanation for the nearly linear serum 
values seen in patient *25. Finally, the bioa33ay is subject to a certain 
degree of variablity in its implimentation and errors are possible. On the 
reccomendation of our consultant pharmacologist, these three data points 
were removed from subsequent data analysis.89 
All kinetic parameters were calculated to fit the concentration 
equation for a two compartment open system as outlined by Riegelman90 
in which the serum concentration, C, at any time, t, can be characterized 
by; 
C = Ae~at + Be~bt 
The coefficients A and B, along with the hybrid rate constants a and 
b were determined by computer analysis. The beta half-life, Tj^gB, wa3 
given by the equation; T1/2B = ,693/B, The volume of distribution into 
which the drug apparently distributes can be calculated in the two 
compartment system by the equation: 
Vd = Da/CBa+ab) 
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where D=d03e administered, a and b are the hybrid rate constants and A 
and B are the exponential coefficients (table 1). 
Using a Tukey Multiple Range test no statistically significant 
differences were found in the hybrid rate constants, the exponential 
coefficients, or the elimination rate constants among the three groups. 
There was a considerable amount of variation in these calculated 
parameters, as 13 commonly seen in patient studies. These calculated 
parameters showed differences in the coefficient of variation ranging 
from 22.3% to 92.2%. These values were used to calculate the area 
under the curve values for each patient in the two compartment model. 
Although statistically significant differences were not found in these 
parameters, the AUC values did show a significant degree of variability. 
The area under the curve was calculated for each set of data at 
both eight hours and extrapolated out to infinity. An attmept was made 
to normalize the AUC value to patient body weight. This correction 
factor was generated by taking the original AUC and normalizing this 
value to that of a 70kg individual; 
NAUC = AUC * pt. body wt./70kg 
This provided another value for analysis which assisted in compensating 
for changes in concentration due to differences in body weight. The 
average normalized area under the curve at eight hours (NAUC8) was 
noted to be 283, 285, and 134 for groups one through three respectively. 
Individuals within a group demonstrated wide degrees of variation. The 
range of values in group one spanned from 118 to 685 with a standard 
deviation of 116 and a coefficient of variance of 41%. In group two the 
values ranged from 241 to 368 with a standard deviation of 57 and a 
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coefficient of variance of 20%. in the third group the values ranged 
from 93 to 212 with a standard deviation of 33 and a coefficient of 
variatiance of 24% (table 1). In virtually every instance the area under 
the curve as described 33 either; AUC, NAUC, AUC8, or NAUC8, revealed 
data which followed the same pattern from high area values in group one 
through intermediate values in group two to low values in group three. 
Concentration-time curves were generated for each of the three 
groups (figure 2). This graph shows group one with the highest serum 
concentrations over time and group three with the lowest serum 
concentrations, while group two was intermediate. The difference 
between groups one and three and groups two and three was found to be 
statistically significant. While the averages differed for groups one and 
two, thi3 difference was not found to be statistically significant. 
The degree of blood loss wa3 also correlated to the area under the 
curve and this relationship was graphed (figure 3). In this analysis a 
linear relation was observed between the degree of blood loss and the 
AUC with a standard deviation of .00628. Thi3 line is described by the 
equation; 
AUC = -,014(deg. blood loss) + 326.1 
When the volume of distribution of the antibiotic was compared to 
the body weight of each patient it was discovered that only a small 
percentage of the variation in the volume of distribution could be 
attributed to differences in body weight. The R2 for this relationship was 
found to be .013 thus indicating that only 1.3% of the observed variation 
in the apparent volume of distribution could be attributed to variations in 
patient body weight (figure 4). The standard deviation was found to be 

33 
15,2. The equation for this relation 13 described as; 
Vd = ,105(pt, weight) + 7.32 
All patient characteristics were compared in order to rule out 
selection bias in any particular group. Average values such as BUN, 
creatinine, and HCT were compared and standard deviations were 
calculated for each. Basically, the three groups were noted to be 
homogeneous with regards to laboratory values, age, and weight (figure 
5), However, group two which consisted of only four patients contained 
all males and did show minor variation with regards to certain 
laboratory values such as the hematocrit, serum hemoglobin, and body 
weight. One patient (4P22) was excluded from serum creatinine, blood 
urea nitrogen, hemoglobin, and hematocrit determinations due to renal 
failure which gave highly deviant values. 

Table 1. 
SUBJECT cnPT A 3 ALPHA BETA AUC Tl/2 V KG NAUC AUC3 MAUC3 
r 3 2 33.9 49.1 1.99 0.229 259 3.02 16.9 63.0 252 225 220 
5 1 o.To 294 2.31 11.4 65.3 276 267 251 
7 2 151.0 70.2 2.39 0.343 254 1.99 11.3 44.0 160 242 171 
9 1 0.704 233 0.93 5.01 63.5 257 232 256 
10 1 1.020 113 0.63 3.35 70.3 119 113 113 
11 2 364.0 39.1 11.7 0.527 200 1.31 9.49 70.0 200 193 193 
12 1 0.521 235 1.33 3.13 55.0 125 231 132 
13 2 123.0 34.5 2.37 0.262 363 2.65 10.4 70.3 370 327 329 
n 16 2 63.7 56.9 1.23 0.134 359 3.77 15.1 104.3 535 223 405 
17 2 232.0 57.3 3.33 0.123 539 5.63 15.1 52.2 402 363 223 
13 2 276.0 103.0 13.2 0.145 732 4,73 9.42 95.3 997 509 635 
19 2 241.0 92.0 16.2 0.377 259 1.34 10.2 67.5 250 247 239 
1 20 1 0.734 221 0.33 5.76 55.3 176 221 176 
1 21 2 102.0 109.0 4.23 0.350 335 1.93 3.53 65.0 311 317 296 
II 22 2 213.0 73.3 13.9 0.156 512 4.43 12.5 63.9 504 369 363 
23 1 0.449 201 1.54 11.1 63.0 195 195 190 
1 24 2 155.0 36.6 6.15 0.323 290 2.12 10.5 76.2 316 270 292 
I 23 2 93.7 79.3 3.60 0.212 403 3.27 11.7 60.0 345 333 239 
29 2 30.5 57.3 2.46 0.142 435 4.37 16.2 31.6 507 307 352 
SO 2 57.7 31.2 1.30 0.172 504 4.02 11.5 67.1 433 335 370 
1 32 2 272.0 97.9 15.1 0.395 266 1.76 9.52 72.6 276 255 264 34 2 133.0 44.7 2.59 0.133 373 5.03 19.4 30. Q 426 266 297 
KEAN 1.73 165.7 77.3 6.73 0.353 333 2.74 11.3 69.2 343 232 223 
SO 0.46 90.3 19.5 6.01 0.235 140 1.51 3.52 13.3 190 31 116 
cvs 26.4 54.5 25.2 33.7 65.7 41.4 55.2 31.3 19.2 55.6 23.7 41.0 
ii 1 2 144.0 30.7 10.4 0.556 159 1.25 11.3 113.3 270 157 257 
14 2 94.1 45.5 1.66 0.223 256 3.04 17.1 77.1 232 224 241 
15 1 0.322 236 2.15 10.9 97.5 393 264 363 
31 2 72.3 44.1 3.15 0.135 349 5.13 21.2 31.6 407 239 274 
KEAN 1.75 103.5 56.3 5.07 0.310 263 2.39 15.1 93.3 339 221 225 
SO 0.50 36.3 20.7 4.63 0.131 79.1 1.66 4.95 18.9 73.4 45.6 56.9 
cv* 23.6 35.5 36.5 92.2 58.3 30.1 Sy.l 32.7 20.1 21.6 20.6 19.9 
ni i 2 211.0 77.7 9.23 0.413 209 1.66 11.4 55.0 164 202 164 
2 2 157.0 70.7 5.72 0.345 232 2.01 12.5 46.3 153 219 154 
6 2 53.3 4.43 0.77 0.037 120 7.99 96.1 77.0 . 132 94 97 
33 2 73.6 31.5 6.73 0.352 242 1.97 11.7 50.0 173 229 166 
i 35 1 0.736 120 0.94 11.4 ■ 54.4 93.3 120 93 1 37 2 205.0 61.7 16.0 0.302 217 2.29 15.3 45.0 140 199 132 
39 2 91.3 57.4 4.28 . 0.264 239 2.62 15.3 70.0 239 212 212 
KEAN 1.33 140.0 59.2 7.70 0.373 190 • 2.31 26.4 54.6 143 177 134 
SO 0.41 73.3 31.5 5.57 0.211 55.4 2.53 34.2 11.7 23.5 56 33 
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In the present study all patients were analyzed according to either a 
one or two compartment model. The ideal pharmacokinetic model for 
cefazohn is known to be the two compartment model. In approximately 
247, of these patients the data did not fit the two compartment model. 
In these cases there was an insufficient number of data points in the 
alpha distribution phase causing the A and alpha terms to poorly fit the 
two compartment model. Thi3 was not unexpected, even from the outset 
of the study. As thi3 was a patient 3tudy and the samples were drawn 
during an operative procedure, it was decided to obtain the smallest 
number of samples possible while still providing enough samples to allow 
a detailed pharmacokinetic evaluation of the data. It was decided to 
draw a total of seven samples as this would allow sufficient data points 
to analyze the alpha and beta phases of the distribution curve. It was 
felt that more samples than this might contribute to unnecessary 
interference with the operative procedure and possibly present a 
confounding factor contributing to the total blood loss as each blood 
sample consisted of six milliliters of blood. As a result of this decision, 
in a small percentage of patients, due to either missed sample points or 
individual patient variation, there were too few data points to fit the 
data to the two compartment model. In such cases these patients were 
analyzed according to the one compartment model to determine the AUC 
values. 
Dividing the patients into three groups was a somewhat arbitrary 
decision influenced by the distribution of patients with regard to blood 
los3. Figure one illustrates this patient distribution. The designation of 
3ma51, intermediate, and large blood loss reflects an attempt to classify 
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groups in thl3 study rather than giving definitions to degrees of blood 
loss. Certainly what is considered a small blood loss for one procedure 
might represent an excessive blood los3 for a different operation, The 
choice of these three groups allowed group comparisons to be made 
between serum antibiotic levels and the degree of blood loss. 
In an attempt to analyze the data on a more continuous scale, the 
blood loss was correlated to the area under the curve simultaneously for 
all three groups. The area under the curve (AUC) is considered to be one 
of the most sensitive pharmacokinetic parameters in analyzing 3uch data. 
The AUC gives an integrated value which is representative of the total 
amount of agent in the body over a period of time. The AUC tends to be 
subject to less variation than other calculated pharmacokinetic variables 
such as the elimination half-life, the exponential coefficients, and the 
hybrid rate constants. 
The normalized area under the curve at eight hours was compared 
among all three groups. Using the Tukey Multiple Range test it was found 
that the NAUC8 for group three was significantly smaller than that for 
either groups one or two. While the NAUC8 for group two was smaller 
than that for group one, this difference was not found to be statistically 
significant. This indicates that those patients with a blood loss in excess 
of three liters have significantly reduced levels of cefazolin when 
compared to a similar group of randomly selected surgical patients 
sustaining minimal blood I033. Although the differences between groups 
one and two were not statistically significant, they did follow the same 
pattern. It is likely that with a larger sample size in group two a 
statistically significant difference would in fact be revealed. 
This difference in serum levels of cefazolin was also clearly 
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demonstrated in figure two. The average serum values for each group 
were graphed against the degree of blood loss. Group one shows the 
highest serum values of antibiotic while group two is intermediate and 
groups three shows the lowest serum values of antibiotic. 
When these values are compared to a sample of healthy volunteers 
not undergoing an operative procedure, it is noted that the surgical 
patients have significantly reduced plasma antibiotic levels, especially 
during the first four hours of antibiotic administration. These control 
studies demonstrate cefazolin reaching peak concentrations in five minutes 
of 108 micrograms/'ml. Thi3 value dropped to 16.5 mcg/mi at four hours, 
yet remained above the values seen in all three groups in this study up 
to this point. At eight hours the healthy volunteers had attained 
approximately the same antibiotic levels as the surgical patients in this 
study.91 
One of the objectives of this study was to attempt to define an 
optimum redosing period for this agent if blood 1033 could be correlated to 
serum levels of the antibiotic. The degree of blood loss vs the area 
under the curve reveals a linear relationship between the amount of 
serum antibiotic in the circulation and the degree of blood loss. In order 
to accurately predict the optimal redosing schedule for patients with a 
significant degree of blood loss, the reference curve from healthy 
volunteers was carefully analyzed and revealed redosing at eight hours 
when the serum level was approximately 6 meg/me!. This is 
approximately three times the MIC of cefazolin for staphylococcus aureus, 
however, the MIC of cefazolin for Enterococcus and methicil!in-resi3tant 
Sthapylococcus aureus is in excess of 30 mcg/'ml,92 Most patients in this 
3tudy had values lower than this within the first four hours of antibioic 
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administration. Although all three groups in this study had comparable 
3erurri values to the healthy volunteers at eight hours, they had 
significantly lower values during the first four hours of this period. 
It is clear from the graph of the degree of blood loss vs the AUC 
that the greater the blood loss, the less the antibiotic concentration. 
This would indicate a possible estimated redo3ing schedule based on the 
degree of blood loss. This is of course subject to a certain degree of 
variation in the individual patient. 
Although there are benefits to maintaining high antibiotic levels in 
surgical patients, these must be weighed against the potential risk of 
toxicity along with the co3f of extra antibiotic dose3. It may be further 
argued that as long as the serum values remain above the therapeutic 
MIC concentrations, there should theoretically be no need to redo3e. Since 
all groups in the study did maintain values above the MIC for many of the 
commonly encountered organisms, this might appear a valid arguement. 
However, standard dosing regimens are such that serum levels several 
times that of the MIC are continually maintained. This is further 
supported by the fact that although serum levels are in excess of the 
MIC, diffusion into tissues or abscesses is dependent on first-order 
kinetics. The higher the initial serum value, the greater the degree of 
interstitial diffusion, and hence the higher the tissue levels. So if would 
seem that there are clear benefits ta maintaining serum values which are 
several orders of magnitude greater than the MIC in order to maintain 
adequate tissue levels. The question of toxicity is not as significant with 
cefazalm, or any of the first generation cephalosporins which are 
associated with a high therapeutic index as compared to the ototoxicity 




Although this study attempted to examine an unbiased homogenous 
patient grGup, as with all patient studies there was a significant degree 
of interpatient variation. Although overall patterns were observed in 
each of the patient groups, there was a significant degree of variation. 
Some of the factors contributing to this variation include the fact that 
the degree of blood loss was an estimation and not a quantified value, it 
was felt that a combined estimate of the surgeon, anesthesiologist and 
researcher would provide a relatively accurate estimate of the total 
blood loss. Quantifiable techniques such as RBC labelling, weighing 
sponges, and dye dilution techniques were deemed inappropriate due to the 
technical difficulties in their implementation along with the confounding 
effects of plasma expansion with crystalloid and RBC infusions during the 
operative procedure. While this technique of estimation introduces a 
certain degree of variability it was combined with knowledge of the 
volume of crystalloid and units of RBC administered in order to give a 
more accurate estimate of the total degree of blood loss. 
Another factor contributing to variation was the fact that individual 
patients were undergoing a variety of different operative procedures. 
There was also a certain amount of variation in the type of anesthesia 
which wa3 administered. it is possible that these factors may have 
influenced the volume of distribution of the antibiotic. There are also 
interpatient variations in plasma binding, distribution, and renal excertion 
of the antibiotic. These effects were grossly controlled for by checking 
common laboratory values such as serum protein/albumin, and tests of 
renal function such as BUN, and creatinine both pre and post operatively. 
The small sample sizes of the groups necessitated larger differences 
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in average values in order to obtain statistically significant differences. 
Perhaps if group two had more patients it would also have revealed 
statistically significant differences as did groups one and three. If would 
also have been helpful to observe a larger number of patients with blood 
loss in excess of three liters and to have perhaps a fourth group 
consisting of patents with a blood loss in excess of six liters, as is 
commonly seen in patients with extensive burns. 
In conjunction with previous studies, it was found that this groups of 
surgical patients demonstrated wide variations in the apparent volume of 
distribution of the antibiotic (figure 4), Lean body mass is often 
considered to correlate with the estimated volume of distribution. While 
this relation may hold for certain patients, this study demonstrates that 
surgical patients are a special category undergoing unique 
pathophysiological variations which contribute to wide variations in the 
apparent volume of distribution, it is furthermore demonstrated that only 
1.3Z of thi3 variation in the apparent volume of distribution could be 
attributed to differences in patient weight. 
There are a few issues which this study raises that have yet to be 
solved, in the first place, the question of when to redose has not been 
completely answered. it has now been 3hcwn that significant blood loss 
leads to depressed antibiotic levels, however, there are significant 
interpatient variations in serum antibiotic levels regardless of the degree 
of blood loss. The graph of the area under the curve vs blood loss and 
the observation of significantly lower blood levels of antibiotic in those 
patients with a blood loss in excess of three liters helps to provide 
guidelines as to more appropriate dosing yet further clarification of exact 
dosing schedules remains. 
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Although this study did demonstrate decreased antibiotic levels as a 
function of blood loss, the 3tudy did not address the effect of this 
decreased level on the incidence of post-operative infection. While the 
serum levels of antibiotic are sigmficatly reduced in patients with a 
significant blood loss, the effect of these decreased levels on the rate of 
post-operative infection has yet to be determined. Furthermore, due to 
the relatively low incidence of post-operative infection in such cases, it 
would be necessary to examine a much larger sample 3ize with several 




This 3tudy demonstrates that integrated antibiotic levels can be 
described as a function of the degree of blood loss in a patient undergoing 
an operative procedure. it has also been shown that there is a linear 
relation between the degree of blood loss and the antibiotic levels with 
greater blood loss resulting in depressed serum antibiotic levels. 
By dividing patients into three arbitrary groups it was discovered 
that those patients with a blood loss in excess of three liters had 
significantly reduced serum antibiotic levels when compared to groups one 
and two. While group two had lower serum antibiotic levels than group 
one, this difference was not found to be statistically significant. This 
was attributed to the small sample size in group two. 
As demonstrated in previous studies of surgical patients, the 
patients in this study demonstrated wide variations in the apparent 
volume of distribution. Only a small percentage of this variation could be 
attributed to differences in patient weight. This variation was attributed 
to the variety of pathophysiologic changes commonly seen in surgical 
patients. 
As a result of these findings more frequent antibiotic dosing is 
reccomended in those patients sustaining significant levels of blood loss 
during an operative procedure. Further studies remain to determine the 
optimum redosing schedule in those patients with a large blood loss. 
The benefits of increased dosing of antibiotics must be weighed in 
consideration to the added expense to the medical industry. Future 
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studies quantifying the incidence of infection with relation to the degree 
of blood loss will be instrumental in deciding this issue. It is also noted 
that there are wide interpatient variations in antibiotic levels such that 
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The Effect of Blood Loss During Surgery on the 
Pharmacokinetics of Per i oper at i ve 
Antibiotic Prophylaxis 
You are invited to participate in a study o-f antibiotic 
usage at the time o-f surgery. The antibiotic for this 
research will be cefazolin, This antibiotic is one of the 
most commonly used at the time of operations such as the one 
you are about to undergo. You have been chosen for this 
study because you are a candidate for one of the follow!no 
yps'= of burgery; hand surgery, prosthetiL implants U a ^ 
hip rep 1 acernsnt, i mp 1 ant breast reconstruct i on , f racture 
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other t r a uma = 
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or not. 
wt; have used some technical t e r i n s i 11 t h i 3 t or in u P1 e ase 
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The Effect of Blood Loss I)ur i nq Su.r qer y on t he 
Pharmacokinetics of Perioperative 
Antibiotic Prophylaxis 
ent_I n f or rna11 on 3he01. 
K e s e a r c h e r 3« D r t, R i c h1 a. r d S t a. hi 1 
I.' r = V1 n c e n t A n c! r 1 o 1 e 
u a rn e s A = A r m s t r o n g 
F-!at i sn t s n1 a.me “ 
Patients address” 
3 i r t h / 
g h t = 
Keasun t or i iusp 1111 1 z a. 11 01! l 
1 y 111 o f s u gery t ~ig performed 
01 h e r m e d i c a t i o n s 
Prophy1actic antibiotic being used;_ 
qat e sc.dedu.X ed f or 3u.r g er v = / 
date of r el ease l_/_/_ 
A n y p a s t h i 31 o r y o f k i d n e y d i s e a s e ? _ 

Su.r qery recor d : 
a n e s t h e s i a s t a r t e d :_< a m / p rn) 
s u r g e r y s t a r ted:_(a rn / p m) 
s u r g e r y c o m plated:_(a m / p m) 
a n e s t h e s i a c a rn plated:_(a m / p m) 
T o t a 1 v q 1 u rn e o f t r a n s t u sions! 
Total vo 1 u.rne of crvsta 11 oid: 
Anest het i c used : __ 
Estimated blood 1oss: 
Surgeon:_ 
Anesthesiologist:_ 




_before surgery ! eight hours after surgery 
hematocrit:_ 
s e r Lt sti p r a t e i n a 1 b u m i n : 





Plasma cephalosporin levels during surgery: 
<measured f r om t i rne o f i n j ec ti on of anti bi ot i c) 
readinq # exact time drawn via 
0 —start— 
1 (5 m i n ) 
ud. t. j. -.j in i n c / 
3 (45 rnin u ) 
4 (90 iTtin= ) 
5 (120 mine ) 
o (4 hrs.) 
7 (8 hrs.} 









Code # Dat 2 Ot b i r t h Type at surgery Weight 
1 ‘Mar -r 
nr ;cr ■—) ■_1 D e b r» S p. W 0 u n d 55, 0 kg 
'“r Ju.l 26 34 Bi 1 at. Mas. Im. Rec0n . 46.3 kg 
~T Sep 21 'T O L. I s c h . P r e s s. S 0 r e R 68.0 kg 
4 Nov 29 31 Reap 1 = Abd. Aortic An. 118, £ kg 
nr 
U Jun 56 Pi10nid a1 sin us t r ac t 65.8 kg 
6 Dec 20 48 Exc+SG Up, body burns 77.0 kg 
7 Mar 19 27 H e m i g 1 0 s s e c t a m y 44. 0 kg 
8 Aug 
er 
U 16 Pec, FI ap C10sure 54.4 kg 
9 Dec 10 72 Nail L, Hip 63.5 kg 
10 Nov 16 44 P 0 s t, T h 0 !•■'. S p , R e d . 70.3 kg 
1 1 Mar 27 •T*?* Peustcw proc. 70. 0 kg 
12 Mar r~t '-j 50 L, F r 0 n , C r a n i 01 o m y 55.0 kg 
13 Jun 43 Bi1. Mastsetamies 70.3 kg 
14 Jun 20 62 L. Hip Curr e 11a g2 77, 1 kg 
15 Sep 3 18 L Li m b a r L a rn i n e c 10 m y 97.5 kg 
16 Mar 19 O T Exp. Lap. 104, 3 kg 
17 Aug 17 46 R, Cheek Fix. 
cr ■-*•» ~ U a:- u .li. kg 
18 Mar yT ■T* “7 Ch alecyst sc10my 95,3 kg 
19 Nov 1 72 SG. to L, Ant, Thigh ' -7 cr & / u X-J kg 
20 Sep 4 68 R e d , M a m m 0 p 1 a s t y 55. 3 kg 
21 Feb 8 57 Radia1 Ar m Flap 65.0 kg 
22 Jan 16 *■"? *7* P s e u d 0 a n e u. r y s m 68.9 kg 
: -7- 
Jun 6 ~T T R, T e mpor ai Lobec10my 6 8. O kg 
24 Apr a 
-v 
L a rn. a n k 1 e at h rod e s i s 76.2 kg 
r~\ nr ..2 □ct 28 58 Pancreate c 10my 82.0 kg 
26 Aug 18 20 Exp. Lap, 87. 0 kg 
27 Sep O T 18 Lip. Res. Max ill. 77. 1 kg 
28 Dec 19 40 THR 60.0 kg 
29 Get 3.1 
“T 
R. C a r 01 i d E n d a r . 81,6 kg 
30 Mar 24 15 t e rn. — t a m „ b y p a s s 67. 1 kg 
31 May 31 49 THR 81,6 kg 
“T 
Get 11 •*T-rr •J* -J Fern, bypass 72.6 kg 
Dec 26 / -_J Skin Grafts 50 „ 0 kg 
34 Nov 3 19 P i n n e c 10 rn y,, e t c . . . 80.0 kg 
~r i~ •.:» --j □ct 2 b 60 Skin grafting 54.4 kg 
36 Nov 6 37 S i g C 01 0 310 m y 61.2 kg 
0* / Sep 13 30 skin graft 45 „ 0 kg 
38 Jul 15 43 d i sarti cu 1 at i 0n 1 „ 1 e 60.0 kg 
39 Apr 28 42 excise burn.skin graft 70 kg 
40 Apr 28 42 s k i n g r a f t s 70 kg 
41 Feb 6 38 exc i si 0ngraf t burns SO kg 
42 Apr 13 56 d e b rid eman t 0f burns 100 k g 

Page 1 File;: ce „ f i I e2 
R epartl cet = ma12 
C od e # Prop h yiactic 01her medic atie n s D a t e o f b u r g e r y 
1 Ancef tobramycin Jul 9 S7 
Ancef D a 3. m a n e. M i d a cola n Ju.l 14 87 
“T Ancef none Jul O T 37 
4 Ancet K-tabs, Tagamet Ju.l 23 87 
nr Ancef Valiam Jul 23 87 
6 Ancef C e f a d y 1 , h a 1 d o 1 Jul 31 37 
■7 Ancef MidazaI an Aug 4 37 
8 Vanc dmvein/Gent a none Aug nr uj 87 
9 Ancef none Aug 6 37 
10 Ancef none Aug 7 87 
i i Ancef Dernerol . Dal m an e Aug 10 87 
12 Ancef V a 1 i u. m, D a 1 m a n s Aug IS 37 
13 Ancef none Aug IS 87 
14 Ancef Demerol Aug 19 37 
15 Ancef none Aug nr ^LU 87 
16 Ancef Amp ... Gen t. , C1 i n d „ Aug 26 87 
17 Ancef none Aug 27 37 
IS Ancef Procardia Aug 27 87 
19 Ancef none Aug 23 37 
20 Ancef VerBed Aug 28 37 
21 Ancef none Aug 31 87 
Ancef Prazosin, Zantac Aug 31 37 
'**> Ancef Thor az me, DPH Sep 1 37 
24 Ancef C a paten, V a 1 i u. rn Sep 1 87 
nr Ancef Heparin, Z a n t ac Sep 37 
26 Gentanycin none Sep o 87 
27 Gentamycin, Ok ac L i b r i u m, C1 e o c i n Sep Tt 87 
28 Ancef none Sep T 87 
29 Ancef Mid a solan, Met amuci1 Sep 4 87 
30 Ancef C o u. m a d i n , dig o x i n Sep 9 87 
31 ■ Ancef none Sep 1 0 t '~j / 
T Ancef none Sep 10 87 
~r; ~r Ancef none Sep 15 87 
34 Ancef D a 1 m a n e, V a 1 i u m Sep .cd. '7 r~- —r O / 
35 Ancef none Nov- 4 87 
36 Gentamicin none Dee 4 87 
.7 "7 Ancef Tobramycin Dec IS 87 
38 Gentamicin, S 0 m g Ep i . ? d opa., Nafici1 J an 1 0 88 
39 Ancef none Mar 3 88 
40 Gentamicin none Apr 7 88 
41 Ancef ranitidine Jul 9 38 




Code # Vq 1 „ of t rans f u.s i on s Vo 1» of c i" y s t a 11 o i d Anesthetic 
1 20 u 17000cc nitrous oxide, 
'“i 6u. SOOOc: c Ethrane 
~T o 1400 cc Pentanyl? Ethra 
4 4 Li 5200 cc Enf lur, Duramor 
cr •_J o 2050 cc spinal block 
6> 16 u 12,900 cc ethrane 
7 o 6100 I sof 1 urab 1 e 
S , 5 Lin i t 750 cc Fentanyl 
9 0 1200 cc Enf1 ourane 
10 o 5500 cc Fentany1 
l i o 4000 c c I sc-f uran 
12 ill 2:700 Vecuron 
13 0 lOOOcc Ethrane 
14 o 3600cc Enf1urane 
15 0 10,000cc Isofuranyl 
16 0 450c c Yc ur an 
17 o 1700cc Ethrane 
18 o 1600.cc En•? 1 ur , Fentany 
19 0 1600cc Fentanyl, Ethra 
20 0 2700cc Ethrane 
21 0 390Occ E p ha d r ane, Fent 
•—> •—i o 80c c Pent anyl, spina 
T 0 1450cc Etnrane, Fentan 
24 o 120Occ Spinal block, ki 
25 0 SOOOcc Midazol 
26 0 4500cc Isof1ur, F ent an 
0 4600ce Ethrane 
28 0 1700c c Ethrane 
29 0 2000cc Fentanyl, Wyami 
30 o 1700cc Pentanyl, Verse 
31 3u. 4000cc W y a m ins, V e c u. r a 
“7* -*3 o 2400cc F e n t a n y 1 , F' a n c = 
33 11 a 5 u 6100cc Fentanyl, Ketorn 
34 o 620Occ E n f 1 u. r a n e, V e c u 
35 15u 4800cc F e n t a n y 1 , V e c u r 
36 2u. 4000c c: Fentanyl, Foran 
““ “7 
7u 3500cc nit rous oxids,i 
33 7u 3500cc n / a 
39 34u 6900cc etnrane 
40 12u 4800cc ethrane 
41 12u 7000c c etnrane 





i ce afi1s2 
Re port» cef« mat4 
Co de # Bloc d 1 G 3 3 ( 3 u. r ) B1 ood 
— — - - 
__  
i 3600 cc 
. ’i y ' 0 l~l ~ 
3600 c 
-r 
/ 3 c c “7! if") 
4 -7. _ . 
-* 2 0 U 0 c 
vJ 123 rr 1 25c c 
6 9500c c 9500cc 
~7 r-1 cr f’\ 
P l J ( f l 
3 15 0 c c 50 rr 
Q -r ..... 
luu rr 
a .•*• /« 1— 
Ai‘ vj 2-' C 46n ,--c 
1 1 500 cc 50)0 rr 
1 O .jO0c c 400rr 
1 3 230c c 25 Or r 
1 /f 
a. -I- j. 40ucc .1 400)1-r 
15 ISOOcc 1OOOcc 
1 6 450c c 4- 3 0 r# r~ 
17 15 0 c c 1 50c c 
1 O 
10 0 c c 150cc 
19 50c c .5 Or r 
aL. L-' \J (j (Z c 660c:c 
d 
J. 100 cc 1 0 0 r* r~ 
150c c 150 c c 
23 800c c 500c c 
24 200c: c 20) Or r 
25 100 0c c L ■)()() —r- 
O / 
.2 0 10 0 c c 1 00 r r 
o 
aC. / jUi'CC 
Cj L- C C 
pp cr /"•. /”•. 
3 n O r* r* 
Q 150 c c 150c c 
O 250c c 250c c 
._i X 500c c 1 2 0) 0) r f 
T'n 
400c c '-‘2- 4 i) i) r - 
T T 
5500cc 5500)c c 
34 70 Or-- 
TET "7 cr _ ... 
/ -_J L_ U 7 C U UC 
•2- O lOOOcc 1 O O O f 
-T- -V 
oOO'Ju C •ibUUcc 
o 3500cc 7" —~ __ _ 
39 1 F i ) () () r" /— 17 0)0> 0 c 4 
40 0 L1 *.•' O C C 6 0? O O r r 
4 1 lJCC 6000cc 
4000cc 4000cc 
HVMu bIOOd 1QS3 
jAUO rr 
3200c c 
75 c r 
2600 cc 
h nnr _ 
i .cl L_ L_ 
9500c c 
525 c c 
10 0 c c 
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20 / 20 
11 / 11 
5 / 5 
10/10 
7 -i / T 
/ X / 7 / 
11 / 1 1 
16 / 5 
15/a 
1 o / 15 
13/12 
12/9. ' 
6 / - 
19/20 
■j q / -j cr 
1 = 2/ 1.0 
=, 8 / , 7 
„ 9/, 9 
.9/7 9 
. S/7 9 
1 , 0 / 1.0 
7/ O ? 
9/ 1.0 
. 9 /, 9 
1. 1 / 1 . 1 
. S / . o 
97/12.9 
„ 9 / - 
n / i“r 
n 7 / . 7 
. 9 / „ 9 
. 8 / . 9 
1.5 / 1.2 
1.0/-- 
. a/, a 
. a/. 7 
M / / - 
o / / a O 
1 a 0 / 1 . 1 
_J / -_J 
5 / A 
i 6 / i 7 
7 /1 o 
a / o 
14 / 2 / 
.4/1„0 
.9/1.3 
. 4/. 6 
1 . 1 / 1.6 
rn / h cr 
~T .~8 
4.6 / — 10.6 
/? o 
'1‘X- 7.0 / 4.5 14 
33« 6 6=1/3.6 i i “r X I a -X' 
44. 1 
cr i / '■*» cr 
Js 1 / Xl 3 --J 15 „ 3 
4x.6 3T7B73T77 14.6 
77 *7> 2.9 / 1.3 11.3 
30.7 / a o / A* a A* 10.6 
'*? —j a 9 / =; 9. 1 
42.3 5.2/2.6 14.2 
41.4 b a 5 / 2 a 6 14a 3 
45.3 / a 1—} : *7 a 15.4 
.-I 4 '—i 
*7 X a xL I 4. 3 
43. 7 14.5 
*7 0 ii .x! 15.2 
^*7 "7 ■i cr “7 
1 J a / 
36.5 6.773.4 12. 0 
40. 3 1 3.7 
33 a 6 11,1 
*tU 3 ^ 13.3 
42.3 
■f t n 
X -X' 3 / 
33.4 13. 0 
24. 1 6.7/3.3 **7 r*» 
n n 
-M-x. a T 14,3 
46.2 7.5/4.3 15.9 
45.5 6= 3/3. 1 14.3 
t cr cr 
c -_J 6„1/3.5 12.0 
34.0 6.0/3.4 11.3 
31,0 5.0/2.7 10. 4 
41.9 6 a 1 / 3 a 4 13» 6 
29.0 Ju 3 / Xn 8 
O 
j a 
45.7 b a 3 / ’2 a V 
■i cr /i 
33. 1 10,3 
34.4 4.3/2. 1 11,6 
■Is £j s -_j 11 = 8 
3 'X sr 
5.4/3.0 1 0,9 
32. 0 5.1/7.6 10- 1 
T / A 
OQ a *1* b U 0* / 2 a _j' 12.4 
"7 cr ^ — 
._J „ l_.« / J. u / Q 
t k / 
•X* X a O 10.6 
47.5 5.6/2.4 i 6, 0 
41.6 7 * 0 / 2 B 5 14 = 4 
. j 3 .J, 4.3 / 3 = 3 
i 2 7 

Fils! l 8.fi1e 2 
R ap art! cef.ma t6 
Code # 1 3 4- 
cr 
U 6 “7 / 
1 172.8 90.9 55. 1 42.4 39.4 1 0.8 5.6 
167,. 6 99.4 65= 1 42.2 29. 1 1 9.0 
nr -r 
x-1 n O 
~r 122.8 1 02 60 no sample 34.5 13.2 .”l “ O O 
4 137.9 80.3 57.8 31.5 25.0 10.6 nn cr aO. 7 « U 
U 94.3 80. 1 70. 4 50.6 46. 1 2 7 n ;"i; 9. 6 
6 51.6 51.7 34.0 21.4 14 5.8 
f~\ Tp 
•**y / 181.9 145. 5 68. 1 39.2 44 16.2 61.0 
s 3. 45 3. 31 3.31 3.06 2. 68 2.06 1 = 41 
9 137.9 161 126 64.6 58.8 8=6 8.9 
10 123.3 86.4 52. 9 21.4 18.2 16a 7 “T 




12 126. 8 95.5 87. 5 56.5 42. 3 no sample no sample 
13 no sample 141.2 87.7 51 = 3 51.8 38.6 8. 4 
14 127.8 105.6 6 U. 8 46. 7 31 „ 3 16.5 8. 1 
15 99. 2 84 2. T O OJ a .!~ 58.3 47.9 26.8 38.2 
16 103. 5 108.5 71» 9 50. 1 46. 9 27.4 50.5 
17 o -n cr -Cl .Cl / n -J 163.9 65. 3 cr t x-JO a a- 47. 1 cr uP. a -_J 6! 2 a 5 
13 193.9 109.6 91.1 75.6 89.5 57.7 31.4 
19 151.9 87.9 69. 1 52. 1 45.2 18.3 cr- %J a a-. 
20 229. 1 1 10. 9 74. 1 63.7 6 6 4. 2 71.1 
21 1 / 6.6 136.9 85 = 3 69.8 51.2 27 SO. 5 
121.7 77.2 63.9 9 1.4 45.5 43.0 90.9 
'n -n- 90. 1 83.9 cr ~y -n 46.4 36.8 16.0 42.6 
24 176.3 115.9 61 „ 1 61 . 1 45 25.8 5 
•—4 “ 
jL. —• 101.4 90.6 79.6 45.0 30.6 11.7 43.4 
O jL 3.68 no sample 2.27 1.67 1.2 no sample 
, —j 
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